Sapacitabine / 151823-14-2
Inquiry
| Post Date: | Aug 18,2016 |
| Expiry Date: | Aug 18,2017 |
| Detailed Description: |
Cas No. :151823-14-2
Quantity: 0.1Kilograms Specs:In-house standard Payment Method: T/T Sapacitabine is a drug undergoing research for potential use in chemotherapy.Sapacitabine is an oral nucleoside analog prodrug that acts through a dual mechanism. The compound interferes with DNA synthesis by causing single-strand DNA breaks and induces arrest of the cell division cycle at G2 phase. Both sapacitabine and its major metabolite, CNDAC, have demonstrated potent anti-tumor activity in both blood and solid tumors in preclinical studies. In a liver metastatic mouse model, sapacitabine was shown to be superior to gemcitabine or 5-FU, two widely used nucleoside analogs, in delaying the onset and growth of liver metastasis. |
| CAS Registry Number: | 151823-14-2 |
| Company: | Shanghai Biopharmaleader Co.,Ltd [ China ] |
| Contact: | Brenda Xu |
| Tel: | 021-50180596 |
| Fax: | 021-57758967 |
| Email: | brenda@biopharmaleader.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
